Tizanidine Hydrochloride
- Product NDC
- 55700-865
- 11-digit product format
- 557000865
- Labeler code
- 55700
- Product ID
- 55700-865_d7d32b09-8ea2-433d-b496-240ad15fa1fd
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Tizanidine Hydrochloride
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- Quality Care Products, LLC
- Application
- ANDA209605
- Marketing category
- ANDA
- Marketing start
- 2020-05-28
- Marketing end
- 0000-00-00
- Substance
- TIZANIDINE
- Active strength
- 6 mg/1
- Pharmacologic classes
- Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 55700-865-30 | 55700086530 | 30 CAPSULE in 1 BOTTLE (55700-865-30) | 30 capsule | 2020-05-28 | 0000-00-00 | No | No | Current |